Anti-proliferative effect of glucocorticoids on mesenchymal cells in juvenile angiofibromas

Olaf Wendler1, Julia Dlugaiczyk, Stephanie Birk

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Erlangen, Erlangen, Germany.

Head & Neck
|February 1, 2012
PubMed
Abstract

Insights

Glucocorticoid receptors (GRs) are upregulated in juvenile angiofibromas. Glucocorticoids (GCs) exhibit a greater antiproliferative effect on these tumor cells, suggesting potential therapeutic applications.

Area of Science:

  • Otorhinolaryngology
  • Oncology
  • Endocrinology

Background:

  • Glucocorticoids (GCs) regulate metabolism and inflammation, and suppress tumor growth.
  • Glucocorticoid receptors (GRs) have been detected in juvenile angiofibromas, but their role is unstudied.

Purpose of the Study:

  • To investigate the distribution and function of GRs in juvenile angiofibromas.
  • To assess the antiproliferative effects of GCs on juvenile angiofibroma cells.

Main Methods:

  • Quantitative RT-PCR and immunofluorescence staining analyzed GRs in tissue and cell samples.
  • In vitro antiproliferative effects of GCs were measured using a bromdeoxyuridine (BrdU) assay.

Main Results:

  • Juvenile angiofibroma tissues and cells showed increased GR transcripts and protein compared to nasal mucosa.
  • GCs demonstrated a significantly higher antiproliferative effect on juvenile angiofibroma fibroblasts than on nasal mucosa fibroblasts.

Conclusions:

  • GR expression and GC antiproliferative effects in juvenile angiofibroma fibroblasts present new therapeutic avenues.
  • This research offers novel treatment options for this specific fibrovascular tumor.